HLA-C and neoplasm: Although changes in tumor cells (loss of MHC molecules, loss of tumor antigens, loss of complement or T cellular lysis or NK cell sensitivity) make them a defective target for the immune attack, it is now widely accepted that immunosuppression is primarily the result of the ability of tumor cells to subvert the immune system to their advantage [50,58,60,61,62].